Results 31 to 40 of about 1,952,392 (384)
Immune Dysregulation in Immune Thrombocytopenia [PDF]
Seminars in Hematology, 2013 Immune thrombocytopenia (ITP) is a bleeding disorder characterized by low platelet counts due to decreased platelet production as well as increased platelet destruction by autoimmune mechanisms. A shift toward Th1 and possibly Th17 cells together with impaired regulatory compartment, including T-regulatory (Tregs) and B-regulatory (Bregs) cells, have ...
Weili Bao +2 more
openaire +3 more sources
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine
Journal of Blood Medicine, 2021 The rollout of the SARS-CoV-2 vaccine is underway, and millions have already been vaccinated. At least 25 reports of “immune thrombocytopenia” (ITP) or “thrombocytopenia” following the Moderna or Pfizer vaccine have been added to the Vaccine Adverse ...
J. Helms +6 more
semanticscholar +1 more source
Vaccines, 2021 We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine administration.
Po-Wei Liao +2 more
doaj +1 more source
Sulfasalazine-induced immune thrombocytopenia [PDF]
Postgraduate Medical Journal, 2007 Abstract Sulfasalazine is a well established disease-modifying anti-rheumatic drug commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. Sulfasalazine was generally well tolerated in clinical trials, the most frequently reported adverse effects being adverse gastrointestinal effects, headache, dizziness ...
Luca Cantarini +4 more
openalex +6 more sources
Exacerbation of immune thrombocytopenia following COVID‐19 vaccination
British Journal of Haematology, 2021 There is concern that COVID‐19 vaccination may adversely affect immune thrombocytopenia (ITP) patients. Fifty‐two consecutive chronic ITP patients were prospectively followed after COVID‐19 vaccination.
D. Kuter
semanticscholar +1 more source
Immune thrombocytopenia and pregnancy [PDF]
Obstetric Medicine, 2011 Immune thrombocytopenia (ITP) is not infrequently encountered during reproductive years with an estimated incidence of 0.1–1 per 1000 pregnancies. An international consensus group recently re-defined ITP and outlined standardized response criteria and up-to-date investigation and management.
Susan Robinson, Srividhya Sankaran
openaire +2 more sources
Primary immune thrombocytopenia in children
Pediatria Polska, 2021 Primary immune thrombocytopenia (ITP) is usually a benign and self-limiting disease in children. Due to the complex pathogenesis involving different immunological processes, its course may be unpredictable.
Agnieszka Książek, Tomasz Szczepański
doaj +1 more source
A Retrospective Observational Single-Centre Study on the Burden of Immune Thrombocytopenia (ITP) [PDF]
, 2012 Background: German data on economic consequences of immune thrombocytopenia (ITP) are limited. Patients and Methods: A retrospective, observational study based on chart review of adult patients with a confirmed diagnosis of ITP was conducted at a German ...
Ackermann, Birgit +6 more
core +1 more source
Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
Journal of Clinical Medicine, 2021 Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is associated with frequent bruising and bleeding. Current evidence suggests that low
Anurag Singh, G. Uzun, T. Bakchoul
semanticscholar +1 more source
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
SN Comprehensive Clinical Medicine, 2020 Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has emerged as an important complication of COVID-19. A systematic review was done to analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in ...
Sukrita Bhattacharjee, M. Banerjee
semanticscholar +1 more source